Friday 6 November 2026 Export CHE’s income statement to Excel — free account

Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue: +10.6%
EPS: +23.1%
Free cash flow: −45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%

Follow CHE

Alert me

Market cap: $7.0B
P/E: 25.5×
Fwd P/E: 24.0×
Dividend yield: 0.47%
F-score: 6/9
Altman Z: 11.69
Beneish M: −2.76
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Chemed Corporation (CHE) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Chemed Corporation (CHE) trades at a price to free cash flow of 23.5×. Over the past ten years it has ranged from 13.4× (April 2026) to 59.0× (May 2018); the current reading is higher than 40% of that period. That is above the Medical Care Facilities industry median of 16.0× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CHE/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Chemed Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CHE/metrics/price-to-free-cash-flow">Chemed Corporation (CHE) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	18.7×	(12.94%)
FY2024	21.4×	(33.21%)
FY2023	32.1×	8.11%
FY2022	29.7×	(10.18%)
FY2021	33.1×	68.09%
FY2020	19.7×	(30.41%)
FY2019	28.3×	45.52%
FY2018	19.4×	(51.92%)
FY2017	40.4×	45.41%
FY2016	27.8×	39.98%

Period	Price to free cash flow	Change
Sep 2026	22.2×	18.85%
Jun 2026	18.7×	38.18%
Mar 2026	13.5×	(27.50%)
Dec 2025	18.7×	5.55%
43 more quarters	Free account

Against its own ten years

Low 13.4× High 59.0×

Ten-year median 26.3×

Current reading's percentile 40

Company	Price to free cash flow
FMS Fresenius Medical Care AG & Co. KGaA compare	6.1×
DVA DaVita Inc. compare	8.4×
UHS Universal Health Services, Inc. compare	10.3×
OPCH Option Care Health, Inc. compare	16.8×
PACS PACS Group, Inc. compare	17.7×
CON Concentra Group Holdings Parent, Inc. compare	20.2×
ENSG The Ensign Group, Inc. compare	20.6×
CHE Chemed Corporation	23.5×
LFST LifeStance Health Group, Inc. compare	28.6×
Medical Care Facilities industry median	16.0×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Chemed Corporation (CHE) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on CHE

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on CHE

Stockrow Weekly